| Study title |
The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) |
| Disease or condition |
High risk intraductal papillary mucinous neoplasms (IPMNs) |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Sulindac or placebo |
| Phase |
2 |
| Study site |
Duke University |
| Study location |
Durham, NC |
| Principal investigator |
Joshua Spaete, MD |
| Study coordinator |
Beth Bronoson; Elizabeth.bronson@duke.edu |
| Phone contact |
919-668-2382 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04207944 |
